A volounteer for Clinical trials of one of the most advanced experimental Covid-19 vaccines, which is being developed by pharmaceutical company AstraZeneca and Oxford University, has developed a strange and unexplained illness leading to a forceful “pause” of the trial. A spokesperson for the AstraZeneca vaccine said in a statement Tuesday that “we voluntarily paused vaccination to allow a review of safety data by an independent committee. “This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while…
Read MoreStrange illness strikes Oxford COVID-19 vaccine Volunteer, Clinical trial paused
